Yimmugo Dosage

Dosage

The dosage may be adjusted over time to achieve the desired trough levels and clinical response.

Preparation and Handling

• YIMMUGO is a clear to slightly opalescent, colorless to pale yellow solution. Inspect visually for particulate matter and discoloration prior to administration, whenever the solution and container permit. Do not use if the liquid is cloudy or turbid, discolored, or if it contains visible particulate matter.
• Do not shake.
• YIMMUGO should be at room or body temperature at the time of administration.
• Do not mix with other IGIV products or other intravenous medications.
• Do not dilute.
• YIMMUGO is for single use only. It contains no preservatives. Promptly use any vial that has been entered. Discard partially used vials and unused product in accordance with local requirements.
• Do not use YIMMUGO after expiration date on the product label.

Administration

Administer YIMMUGO at room temperature or body temperature by the intravenous route. Do not mix with any intravenously administered medications. For rate of infusion, refer to Table 1. Monitor patient vital signs throughout the infusion. Slow or stop the infusion if adverse reactions occur. If symptoms subside promptly, the infusion may be resumed at a lower rate that is comfortable for the patient.

Ensure that patients with pre-existing renal insufficiency are not volume depleted. For patients judged to be at risk for renal dysfunction or thrombotic events, administer YIMMUGO at the minimum infusion rate practicable, and consider discontinuation of administration if renal function deteriorates.

Hydrate the patient adequately prior to the initiation of infusion.